"Imperial College London Diabetes" It adopts a new identity to enhance his expertise in endocrine medicine
Abu Dhabi, August 25 / WAM / The Imperial College London Diabetes Center, affiliated with the M42 Global Group, announced the official name of the Imperial College London Diabetes and Endocrinology Center (ICLDEC), thus the center expanded its services to include an integrated group of endocrinology, as well as continuing to lead diabetes management.
The new identity reflects the development of the natural center by integrating the latest technologies in various endocrine majors, including cases related to metabolism, growth, fertility and hormone health.
The center brings together more than 50 specialists and deaf glands accredited from the United Kingdom and the United States of America, making it the largest and most reliable in providing specialized care for diabetics and endocrine disorders in the region, through four strategic locations in the UAE.
Dr. Ali Anis, CEO of Operations at the World Patient Care Platform at M42, UAE and Bahrain, stressed that endocromatic medicine is a basic pillar in the group’s health care system, noting that the new identity of the center reflects the expansion of its specialized services in a way that enhances its leadership in diabetes and endocrine care.
He added that the highlight of the center’s experiences confirms its commitment to providing integrated specialized sponsorship, which will be keen to highlight it during the expected diabetes and endocrine conference next November.
For her part, Dr. Mai Al -Jaber, CEO of the Imperial College London Diabetes, Endocrinology and External Patient Care in M42, said that changing the center’s name goes beyond merely an identity update, as it reflects its future vision and the accomplishments that the center always seeks to achieve for the benefit of patients, confirming the center’s commitment to providing sustainable health care based on clinical excellence and innovation and with the expansion of its services confirms its role as a partner Reliable endocrine care not only inside the Emirates, but in various parts of the region.
The center currently works through its facilities in Abu Dhabi, Al Ain and Al Dhafra area, providing an integrated spectrum of endocrine medicine services for a wide segment of patients. This change in the name enhances the position of the center as a leading authority in specialized care and a reliable partner at the level of the Gulf Cooperation Council countries and the region.
- For more: Follow Khaleejion 24 Arabic, Khaleejion 24 English, Khaleejion 24 Live, and for social media follow us on Facebook and Twitter
